IRIS
FORNARO, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.054
NA - Nord America 8.030
EU - Europa 7.976
SA - Sud America 1.592
AF - Africa 274
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 10
Totale 30.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.709
SG - Singapore 5.792
RU - Federazione Russa 3.049
IT - Italia 2.981
VN - Vietnam 2.380
CN - Cina 2.332
BR - Brasile 1.296
HK - Hong Kong 1.120
FR - Francia 490
JP - Giappone 290
NL - Olanda 260
BD - Bangladesh 253
DE - Germania 251
GB - Regno Unito 178
KR - Corea 157
CA - Canada 142
IN - India 137
SE - Svezia 135
UA - Ucraina 122
AR - Argentina 103
FI - Finlandia 103
MX - Messico 101
CI - Costa d'Avorio 77
ID - Indonesia 76
AT - Austria 71
IE - Irlanda 71
IQ - Iraq 66
PH - Filippine 66
EC - Ecuador 59
TH - Thailandia 57
TR - Turchia 47
PL - Polonia 46
TW - Taiwan 43
ZA - Sudafrica 43
ES - Italia 42
PK - Pakistan 38
CO - Colombia 29
MA - Marocco 28
PY - Paraguay 26
VE - Venezuela 25
CL - Cile 24
HU - Ungheria 24
SA - Arabia Saudita 23
JO - Giordania 20
EG - Egitto 19
UZ - Uzbekistan 19
AU - Australia 18
JM - Giamaica 17
RO - Romania 17
CH - Svizzera 15
IL - Israele 15
LB - Libano 15
IR - Iran 14
AE - Emirati Arabi Uniti 13
DO - Repubblica Dominicana 13
BE - Belgio 12
TN - Tunisia 12
AL - Albania 11
ET - Etiopia 11
HR - Croazia 11
KE - Kenya 11
MY - Malesia 11
PE - Perù 11
AZ - Azerbaigian 10
UY - Uruguay 10
GR - Grecia 9
IS - Islanda 9
PT - Portogallo 9
BG - Bulgaria 8
DZ - Algeria 8
KZ - Kazakistan 8
SN - Senegal 8
NP - Nepal 7
OM - Oman 7
TT - Trinidad e Tobago 7
BZ - Belize 6
GA - Gabon 6
HN - Honduras 6
LT - Lituania 6
MD - Moldavia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
RS - Serbia 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
AO - Angola 4
BO - Bolivia 4
BW - Botswana 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
KG - Kirghizistan 4
LV - Lettonia 4
ME - Montenegro 4
NG - Nigeria 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
BS - Bahamas 3
CG - Congo 3
Totale 30.859
Salva come PNG Salva come JPEG
Città #
Singapore 2.821
San Jose 1.564
Hong Kong 1.079
Moscow 685
Hefei 590
Ho Chi Minh City 566
Ashburn 537
Beijing 458
Dong Ket 449
Hanoi 412
Santa Clara 398
The Dalles 365
Chandler 360
Millbury 342
Lauterbourg 306
Rome 298
Naples 285
Tokyo 258
Princeton 224
Des Moines 206
Nanjing 204
Los Angeles 201
Dallas 182
Milan 178
Redondo Beach 162
Buffalo 150
Amsterdam 144
Council Bluffs 142
São Paulo 127
Seoul 113
New York 101
Da Nang 96
Boston 83
Haiphong 77
Wilmington 77
Seattle 76
Frankfurt am Main 68
Shenyang 65
Turin 59
Lawrence 58
Hebei 57
Orem 57
Nuremberg 56
Nanchang 54
Mexico City 52
Norwalk 51
Napoli 47
Houston 45
Chicago 44
Jiaxing 44
Genoa 42
Rio de Janeiro 41
Bari 39
Brooklyn 38
Munich 38
Ottawa 38
London 36
Helsinki 34
Vienna 34
Catania 32
Tianjin 32
Baghdad 31
Biên Hòa 31
Atlanta 30
Casavatore 30
Toronto 29
Falkenstein 28
Florence 28
Hải Dương 28
Montreal 28
Belo Horizonte 27
Chennai 27
Denver 26
Warsaw 26
Dublin 25
Stockholm 25
Lappeenranta 24
Phoenix 24
Boardman 23
Johannesburg 23
Livorno 23
Palermo 23
Redwood City 23
Brasília 22
Can Tho 22
Changsha 21
San Francisco 21
Bangkok 20
Cagliari 20
Manchester 20
Bologna 19
Curitiba 19
Jacksonville 19
Amman 18
Guangzhou 18
Guarulhos 17
Dhaka 16
Guayaquil 16
Shenzhen 16
Turku 16
Totale 16.379
Salva come PNG Salva come JPEG
Nome #
Disturbo bipolare e malattie disreattive: una relazione complessa 1.055
Disturbo borderline e spettro bipolare: una ricerca epidemiologica 388
Comorbidità tra Disturbo da Deficit dell'Attenzione e Iperattività nell'adulto e Distubo Bipolare - prevalenza e caratteristiche cliniche in uno studio preliminare 320
Associate Editor 237
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 218
Valutazione elettroretinografica (ERG) in pazienti con depressione maggiore in trattamento con duloxetina: differenza tra “responders” e “non-responders” quale possibile indice di un pattern biologico differenziale. 194
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 179
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019 175
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials 172
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 171
A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders 165
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 161
Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials 154
“XLIV Congresso Nazionale della Società Italiana di Psichiatria (SIP) 2006”. Palacongressi d’Abruzzo, Montesilvano (Pescara) 15-20 ottobre 2006. (simposio dal titolo “L’identità dello Psichiatra: le opinioni degli specializzandi in Psichiatria italiani” – abstract book pp.247. 154
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls 152
Impact of sex and complex PTSD comorbidity on pharmacological treatment response in bipolar disorder patients 151
“Duloxetina e Bupropione in Medicina Generale” Aggiornamento ECM per Medici di Medicina Generale. Centro Ricerca G. De Lisio (Coordinatore Scientifico, Prof. G. Perugi), Pisa 15-12-2008. 151
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 151
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis “Nutra NMA SCZ” 144
The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: a study on bipolar I Italian national sample 143
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 141
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings 139
Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? 134
VEGF plasma level variations in duloxetine-treated patients with major depression 131
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations 129
Psychological perspective of medication adherence in transplantation 128
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 128
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 128
Miglioramento clinico con bupropione della Sindrome delle Gambe Senza Riposo indotto dal trattamento con mirtazapna e duloxetina in un paziente affetto da Depressione Maggiore 127
Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician's perspective 127
The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis 127
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 126
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 125
Homelessness and health-related outcomes: an umbrella review of observational studies and randomized controlled trials 124
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 124
Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series 124
The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? 124
The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials 123
Studio dell'Asse Ipotalamo-Ipofisi-Surrene nei pazienti con Depressione Maggiore prima e dopo trattamento con Reboxetina 123
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 123
Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects 122
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 122
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the “real world” everyday clinical practice 121
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 119
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study 119
The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis 119
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders 118
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia 118
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug? 118
NGF serum levels variations in major depressed patients receiving duloxetine 118
Different measures of impulsivity in patients with anxiety disorders: a case control study 118
Mental health during the 2022 Russo-Ukrainian War: A scoping review and unmet needs 117
Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates 117
Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report 117
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 117
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 117
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 117
Prominent autistic traits and subthreshold bipolar/mixed features of depression in severe anorexia nervosa 116
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 115
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis 115
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions 115
Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis 114
Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials 114
The impact of premenstrual dysphoric disorder among 92 bipolar patients 114
How common is bipolar disorder in general primary care attendees? A systematic review and meta-analysis investigating prevalence determined according to structured clinical assessments 114
BDNF plasma levels variations in major depressed patients receiving duloxetine 114
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia 113
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 113
Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years 113
Innova4Health: an integrated approach for prevention of recurrence and personalized treatment of Major Depressive Disorder 112
Regional differences in mortality risk and in attenuating or aggravating factors in schizophrenia: A systematic review and meta-analysis 112
When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia 112
Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds 111
Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review 111
Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment 110
Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament 110
Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors 110
Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample 109
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 109
Medicine and psychiatry in Western culture: among Ancient Greek myths and modern prejudices 109
Celiac disease and ADHD: mini-review and critique 109
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 107
Impulsività e disturbi d’ansia: il ruolo della ciclotimia 107
Corrigendum to “Exploring clinical phenotypes of food addiction and its distress correlates: A cross-sectional evaluation in treatment-seeking individuals with obesity” [Eating Behaviors volume 57 (April 2025), Online ahead of print, 101961] 106
Atypical depression and emotion dysregulation: Clinical and psychopathological features 106
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 105
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders 105
"Novel Psychopharmacology for Depressive Disorders" 105
Defining clinical characteristics of emotion dysregulation in bipolar disorder: A systematic review and meta-analysis 104
Efficacia e sicurezza dell’asenapina in pazienti con episodi maniacali e misti associati a disturbo bipolare I 103
Emotion dysregulation in bipolar disorder compared to other mental illnesses: a systematic review and meta-analysis 102
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management 101
Is there a biosignature for lithium response in bipolar disorder? Evidence and implications 101
"Aspetti etologici e terapeutici della comorbilità tra Depressione e Disturbo Post-Traumatico da Stress" 100
Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report 100
C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis 99
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 99
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 99
Suicide 99
Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: A systematic review 98
Totale 13.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.721
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021499 0 0 0 0 0 0 0 0 0 0 31 468
2021/20221.411 83 14 33 57 30 94 51 68 93 103 147 638
2022/20231.389 307 98 48 59 114 141 36 90 196 145 102 53
2023/20241.613 71 171 145 116 80 60 139 183 73 105 290 180
2024/20258.474 524 744 66 107 277 350 845 653 895 770 2.474 769
2025/202616.359 1.758 1.479 1.761 1.263 2.430 588 1.724 1.312 2.406 1.025 613 0
Totale 31.561